Isabella Michelon, 6th year medical student at the Catholic University of Pelotas, shared a recent article on X:
“Proud to share our work in Therapeutic Advances in Medical Oncology.
Our meta-analysis of 2000+ patients with HER2-low and MBC reveals a 50% reduction in the risk of progression and death with ADCs compared to chemotherapy.”
Authors: Isabella Michelon, Maria Inez Dacoregio, Maysa Vilbert, Jonathan Priantti, Caio Ernesto do Rego Castro, Lucas Vian, Paolo Tarantino, Evandro de Azambuja, and Ludimila Cavalcante
For more updates, follow OncoDaily.